Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics

Molecular Genetics and Metabolism

Volumn 86, Issue 1-2, 2005, Pages 91-99

  Bauduer, F ^a   Lacombe, D ^b  

^a CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Factor V Leiden; MTHFR C677T; Population genetics; Prothrombin 20210A; Thrombophilia; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; PROTHROMBIN 20210A; UNCLASSIFIED DRUG; VITAMIN;

AFRICA; ALLELE; ARTERY THROMBOSIS; ASIAN; BLEEDING; CAUCASIAN; ENVIRONMENTAL FACTOR; EUROPE; FOLIC ACID DEFICIENCY; GENE FREQUENCY; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GEOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; INDONESIA; MOTHER FETUS RELATIONSHIP; NATURAL SELECTION; PATHOPHYSIOLOGY; POPULATION; POPULATION GENETICS; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; THROMBOPHILIA; THROMBOSIS; VEIN THROMBOSIS;

EID: 26244460048     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.04.002     Document Type: Review

References (84)

1. D.A. Lane, and G.J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood 95 2000 1517 1532
2. O. Egeberg Inherited antithrombin III deficiency causing thrombophilia Thromb. Diath. Haemorrh. 13 1965 516 530
3. J.H. Griffin, B.L. Evatt, T.S. Zimmerman, A.J. Kleiss, and C. Wideman Deficiency of protein C in congenital thrombotic disease J. Clin. Invest. 68 1981 1370 1373
4. P.C. Comp, R.R. Nixon, M.R. Cooper, and C.T. Esmon Familial protein S deficiency is associated with recurrent thrombosis J. Clin. Invest. 74 1984 2082 2088
5. P. Couture, E.G. Bovill, C. Demers, J. Simard, R. Delage, B.T. Scott, J.E. Valliere, P.W. Callas, M. Jomphe, F.R. Rosendaal, M. Aiach, and G.L. Long Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French origin Thromb. Haemost. 86 2001 1000 1006
6. B. Dahlbäck, M. Carlsson, and P. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc. Natl. Acad. Sci. USA 90 1993 1004 1008
7. R. Bertina, B. Koeleman, and T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
8. S. Poort, F. Rosendaal, P. Reitsma, and R. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
9. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J.H. Boers, M. den Heijer, L.A.J. Kluijtmans, L.P. van den Heuvel, and R. Rozen A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat. Genet. 10 1995 111 113
10. T. Koster, A.D. Blann, E. Briet, J.P. Vandenbroucke, and F.R. Rosendaal Role of clotting factor VIII in effect on von Willebrand factor on occurrence of deep vein thrombosis Lancet 345 1995 152 155
11. A. van Hylckama, I.K. van der Linden, R.M. Bertina, and F.R. Rosendaal High levels of factor IX increase the risk of venous thrombosis Blood 95 2000 3678 3682
12. J.C.M. Meijers, W.L.H. Tekelenburg, B.N. Bouma, R.M. Bertina, and F.R. Rosendaal High levels of coagulation factor XI as a risk factor for venous thrombosis N. Engl. J. Med. 342 2000 696 701
13. J. O'Donnell, and M.A. Laffan The relationship between ABO histo-blood group, factor VIII and von Willebrand factor Transfus. Med. 11 2001 343 351
14. T.W. Meade, J.A. Cooper, Y. Stirling, D.J. Howarth, V. Ruddock, and G.J. Miller Factor VIII, ABO blood group and the incidence of ischaemic heart disease Br. J. Haematol. 88 1994 601 605
15. U. Seligsohn, and A. Lubetsky Genetic susceptibility to venous thrombosis N. Engl. J. Med. 344 2001 1222 1231
16. D.C. Rees The population genetics of factor V Leiden (Arg506Gln) Br. J. Haematol. 95 1996 579 586
17. T. Antoniadi, T. Hatzis, C. Kroupis, E. Economou-Petersen, and M. Petersen Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors Am. J. Hematol. 61 1999 265 267
18. H.V. Ioannou, M. Mitsis, A. Eleftheriou, M. Matsagas, V. Nousias, C. Rigopoulos, G. Vartholomatos, and A.M. Kappas The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece Int. Angiol. 19 2000 314 318
19. B. Zöller, P. Garcia de Frutos, A. Hillarp, and B. Dahlbäck Thrombophilia as a multigenic disease Haematologica 84 1999 59 70
20. F.R. Rosendaal, T. Koster, J.P. Vandenbroucke, and P.H. Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
21. K. Juul, A. Tybjaerg-Hansen, P. Schnohr, and B.G. Nordestgaard Factor V Leiden and the risk for venous thromboembolism in the adult Danish population Ann. Intern. Med. 140 2004 330 337
22. M.P.M. De Maat, C. Kluft, J. Jespersen, and J. Gram World distribution of factor V Leiden mutation Lancet 347 1996 58
23. G. Lucotte, and G. Mercier Frequency of factor V Leiden (Arg506Gln) Br. J. Haematol. 99 1997 237 241
24. F. Bauduer, L. Ducout, C. Guerre, and G. Freyburger Activated Protein C (APC) resistance: does it exist in the Basques? Br. J. Haematol. 99 1997 712 713
25. 506G and prothrombin 20210 mutations in the Navarrese population Thromb. Haemost. 80 1998 522 523
26. J.M. Soria, M. Baiget, L. Castano, M.I. Tejada, G. Perez-Nanclares, and J. Fontcuberta Genetic risk factors for thrombosis in a Basque population and their possible contribution to the analysis of a complex disease such as thrombophilia Haematologica 86 2001 889 890
27. F. Bauduer, A. Zivelin, A. Degioanni, L. Ducout, O. Dutour, E. Shpringer, and U. Seligsohn The prevalence of factor V G1691A in French Basques, but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T, is remarkably low J. Thromb. Haemost. 2 2004 361 362
28. L.L. Cavalli-Sforza, P. Menozzi, and A. Piazza The history and geography of human genes 1994 Princeton University Press Princeton
29. F.R. Rosendaal, C.J. Doggen, A. Zivelin, V.R. Arruda, M. Aiach, D.S. Siscovick, A. Hillarp, H.H. Watzke, F. Bernardi, A.M. Cumming, F.E. Preston, and P.H. Reitsma Geographic distribution of the 20210 G to A prothrombin variant Thromb. Haemost. 79 1998 706 708
30. A. De Bree, W.M.M. Verschuren, A.L. Bjorke-Monsen, N.M.J. van der Put, S.G. Heil, F.J.M. Trijbels, and H.J. Blom Effect of the methylenetetrahydrofolate reductase 677 C → T mutation on the relation among folate intake and plasma folate and homocysteine concentration in a general population sample Am. J. Clin. Nutr. 77 2003 687 693
31. V.R. Arruda, P.M. von Zuben, L.C. Chiaparini, J.M. Annichino-Bizzacchi, and F.F. Costa The mutation Ala677 → Val in the methylenetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis Thromb. Haemost. 77 1997 818 821
32. J.G. Ray, D. Shmorgun, and W.S. Chan Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies Pathophysiol. Haemost. Thromb. 32 2002 51 58
33. D.S. Wald, M. Law, and J.K. Morris Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 2002 1202 2108
34. A.W. Tsai, M. Cushman, M.Y. Tsai, S.R. Heckbert, W.D. Rosamond, N. Aleksic, N.D. Yanez, B.M. Psaty, and A.R. Folsom Serum homocysteine, thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE) Am. J. Hematol. 72 2003 192 200
35. A.H. Sadewa, S. Sunarti, R. Sumoto, C. Hayashi, M.J. Lee, H. Ayaki, A.S.M. Sofro, M. Matsuo, and H. Nishio The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population Kobe J. Med. Sci. 48 2002 137 144
36. N. Rosenberg, M. Murata, Y. Ikeda, O. Opare-Sem, A. Zivelin, E. Geffen, and U. Seligsohn The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans Am. J. Hum. Genet. 70 2002 758 762
37. G. Pepe, O. Camacho Vanegas, B. Giusti, T. Brunelli, R. Marcucci, M. Attanasio, O. Rickards, G.F. DeStefano, D. Prisco, G.F. Gensini, and R. Abbate Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase Am. J. Hum. Genet. 63 1998 917 920
38. D.S. Rosenblatt, and V.M. Whitehead Cobalamine and folate deficiency: acquired and hereditary disorders in children Semin. Hematol. 36 1999 19 34
39. V. DeStefano, I. Martinelli, P.M. Mannucci, K. Paciaroni, P. Chiusolo, I. Casorelli, E. Rossi, and G. Leone The risk of recurrent deep venous thrombosis among heterozygotes carriers of both factor V Leiden and the G20210A prothrombin mutation N. Engl. J. Med. 341 1999 801 806
40. I. Martinelli, P. Bucciarelli, M. Margaglione, V. De Stefano, G. Castaman, and P.M. Mannucci The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both Br. J. Haematol. 111 2000 1223 1229
41. M. Cattaneo, M.Y. Tsai, P. Bucciarelli, E. Taioli, M.L. Zighetti, M. Bignell, and P.M. Mannucci A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506) Arterioscler. Thromb. Vasc. Biol. 17 1997 1662 1666
42. P.M. Ridker, C.H. Hennekens, J. Selhub, J.P. Miletich, M.R. Malinow, and M.J. Stampfer Interrelation of hyperhomocysteinemia, factor V Leiden and risk of future venous thromboembolism Circulation 95 1997 1777 1782
43. V. De Stefano, B. Zappacosta, S. Persichilli, E. Rossi, I. Casorelli, K. Paciaroni, P. Chiusolo, A.M. Leone, B. Giardina, and G. Leone Prevalence of mild hyperhomocysteinemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease Br. J. Haematol. 106 1999 564 568
44. O. Salomon, D.M. Steinberg, and A. Zivelin Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism. Prevalence and risk assessment Arterioscler. Thromb. Vasc. Biol. 19 1999 511 518
45. A. Zivelin, J.H. Griffin, X. Xu, I. Pabinger, M. Samama, J. Conard, B. Brenner, A. Eldor, and U. Seligsohn A single genetic origin for a common Caucasian risk factor for venous thrombosis Blood 89 1997 397 402
46. A. Zivelin, N. Rosenberg, S. Faier, N. Kornbrot, H. Peretz, C. Mannhalter, M.H. Horellou, and U. Seligsohn A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene Blood 92 1998 1119 1124
47. D.C. Rees, N.H. Chapman, M.T. Webster, J.F. Guerreiro, J. Rochette, and J.B. Clegg Born to clot: the European burden Br. J. Haematol. 105 1999 564 566
48. G. Lucotte, and G. Mercier Population genetics of factor V Leiden in Europe Blood Cells Mol. Dis. 27 2001 362 367
49. D.C. Rees, M. Cox, and J.B. Clegg World distribution of factor V Leiden Lancet 346 1995 1133 1134
50. M.P. De Maat, E.M. Bladbjerg, L.G. Johansen, J. Gram, and J. Jespersen Absence of prothrombin mutation in the Inuit Thromb. Haemost. 79 1998 882
51. R.A. Hegele, C. Tully, T.K. Young, and P.W. Connelly V677 mutation of methylenetetrahydrofolate reductase and cardiovascular disease in Canadian Inuits Lancet 349 1997 1221 1222
52. L. Chikhi, R.A. Nichols, G. Barbujani, and M.A. Beaumont Y genetic data support the Neolithic demic diffusion model Proc. Natl. Acad. Sci. USA 99 2002 11008 11013
53. J. Bertranpetit, J. Sala, F. Calafell, P.A. Underhill, P. Moral, and D. Comas Human mitochondrial DNA variation and the origin of Basques Ann. Hum. Genet. 59 1995 63 81
54. M. Iriondo, M.C. Barbero, and C. Manzano DNA polymorphisms detect ancient barriers to gene flow in Basques Am. J. Phys. Anthropol. 122 2003 73 84
55. P.G. Lindqvist, P.J. Svensson, B. Dahlbäck, and K. Marsal Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss-a possible evolutionary selection mechanism Thromb. Haemost. 79 1998 69 73
56. J. Corral, J.A. Iniesta, R. Gonzalez-Conejero, M. Villalon, and V. Vicente Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage Blood 97 2001 2979 2982
57. W.C. Nichols, K. Amano, T.M. Cacheris, M.S. Figueiredo, K. Michaelides, R. Schwaab, L. Hoyer, R.J. Kaufman, and D. Ginsburg Moderation of hemophilia A phenotype by the factor V R506Q mutation Blood 88 1996 1183 1187
58. B.S. Donahue, D. Gailani, M.S. Higgins, D.C. Drinkwater, and A.L. George Factor V Leiden protects against blood loss and transfusion after cardiac surgery Circulation 107 2003 1003 1008
59. B.A. Kerlin, S.B. Yan, and B.H. Iserman Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia Blood 102 2003 3085 3092
60. M.J. Kupferminc, A. Eldor, N. Steinman, A. Many, A. Bar-AM, A. Jaffa, G. Fait, and J.B. Lessing Increased frequency of genetic thrombophilia in women with complications of pregnancy N. Engl. J. Med. 340 1999 9 13
61. E. Rey, S.R. Kahn, M. David, and I. Shrier Thrombophilic disorders and fetal loss: a meta-analysis Lancet 361 2003 901 908
62. W. Göpel, M. Ludwig, A.K. Junge, T. Kohlmann, K. Diedrich, and J. Möller Selection pressure for the factor V Leiden mutation and embryo implantation Lancet 358 2001 1238 1239
63. K. Juul, A. Tybjaerg-Hansen, and B.G. Nordestgaard Factor V Leiden: relation to fertility Lancet 359 2002 814
64. W.L. Nelen, H.J. Blom, A. Steegens, M. den Heijer, C.M. Thomas, and T.K. Eskes Homocysteine and folate levels as risk factors for recurrent early pregnancy loss Obstet. Gynecol. 95 2000 519 524
65. W.L. Nelen, E.A. Steegers, T.K. Eskes, and H.J. Blom Genetic risk factor for unexplained recurrent early pregnancy loss Lancet 350 1997 861
66. A.G. Motulsky Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid Am. J. Hum. Genet. 58 1996 17 20
67. P.A. Isotalo, G.A. Wells, and J.G. Donnelly Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations Am. J. Hum. Genet. 67 2000 986 990
68. D.P. Burkitt Varicose veins, deep vein thrombosis, and hemorrhoids: epidemiology and suggested aetiology BMJ 2 1972 556 561
69. P.D. Stein, F. Kayali, R.E. Olson, and C.E. Milford Pulmonary thromboembolism in Asians/Pacific Islanders in the United states: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census Am. J. Med. 116 2004 435 442
70. R.K. Patel, E. Ford, J. Thumpston, and R. Arya Risk factors for venous thrombosis in the black population Thromb. Haemost. 90 2003 835 838
71. F. Bauduer, L. Ducout, A. Degioanni, and O. Dutour Is there a "Basque" profile regarding autosomal recessive deficiencies of coagulation factors Haemophilia 10 2004 276 279
72. M. Karimi, H. Yarmohammadi, R. Ardeshiri, and H. Yarmohammadi Inherited coagulation disorders in Southern Iran Haemophilia 8 2002 740 744
73. F. Bauduer, F. Dupreuilh, L. Ducout, and B. Marti Factor XI deficiency in the French Basque Country Haemophilia 5 1999 187 190
74. A. Zivelin, F. Bauduer, L. Ducout, H. Peretz, N. Rosenberg, R. Yatuv, and U. Seligsohn Factor XI deficiency in Basques is predominantly caused by an ancestral C38R mutation in the factor XI gene Blood 99 2002 2448 2454
75. A. Tordai, I. Klein, K. Rajczy, M. Penzes, B. Sarkadi, and A. Varadi Prevalence of factor V Leiden (Arg 506 Gln) in Hungary Br. J. Haematol. 99 1997 467 472
76. N. Akar, E. Akar, G. Dalgin, A. Sozuoz, K. Omurlu, and S. Cin Frequency of factor V (1691 G → A) mutation in Turkish population Thromb. Haemost. 78 1997 1527 1529
77. C. Ferrer-Antunes, A. Palmeiro, and F. Green Polymorphisms of fibrinogen, factor VIII and factor V genes. Comparison of allele frequencies in different ethnic group Thromb. Haemost. 73 1995 1834
78. L.D. Botto, and Q. Yang 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review Am. J. Epidemiol. 151 2000 862 877
79. R.F. Franco, A.G. Araujo, J.F. Guerreiro, J. Elion, and M.A. Zago Analysis of the 677C → T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups Thromb. Haemost. 79 1998 119 121
80. M. Adams, P.D. Smith, D. Martin, J.R. Thompson, D. Lodwick, and N.J. Samani Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction Q. J. Med. 89 1996 437 444
81. X.M. Li, Y.F. Wei, H.L. Hao, Y.B. Hao, L.S. He, J.D. Li, B. Mei, S.Y. Wang, C. Wang, J.X. Wang, J.Z. Zhu, and J.Q. Liang Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome Am. J. Hematol. 71 2002 11 14
82. M. Zuo, M.J. Lee, M.H. Kim, Y. Wu, H. Ayaki, H. Nishio, and K. Sumino C677T mutation of the methylenetetrahydrofolate reductase gene among the Korean infants in Seoul city Kobe J. Med. Sci. 45 1999 271 279
83. A. Tosetto, E. Missiglia, M. Frezzato, and F. Rodeghiero The VITA project: C677T mutation in the methylenetetrahydrofolate reductase gene and risk of venous thromboembolism Br. J. Haematol. 97 1997 804 806
84. O.M. Mutchinick, M.A. Lopez, L. Luna, J. Waxman, and V.E. Babinsky High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a high prevalence of neural defects Mol. Genet. Metab. 68 1999 461 467